E-cigarette prevalence among Malaysian adults and types and flavors of e-cigarette products used by cigarette smokers who vape: Findings from the 2020 ITC Malaysia Survey.
Malaysia
e-cigarettes
flavors
nicotine
prevalence
Journal
Tobacco induced diseases
ISSN: 1617-9625
Titre abrégé: Tob Induc Dis
Pays: Greece
ID NLM: 101201591
Informations de publication
Date de publication:
2022
2022
Historique:
received:
23
11
2021
revised:
28
01
2022
accepted:
02
02
2022
entrez:
18
4
2022
pubmed:
19
4
2022
medline:
19
4
2022
Statut:
epublish
Résumé
E-cigarettes (ECs) have become increasingly common in many countries, including Malaysia. The prevalence of EC use increased in Malaysia from 0.8% in 2011 to 4.9% in 2019. Three quarters of Malaysian EC users also smoke combustible cigarettes, and the prevalence of EC use among Malaysian smokers in 2014 was consistent with the prevalence of use among smokers from Canada and the US in 2016. The purpose of this study was to estimate the prevalence of EC use among Malaysian adults aged ≥18 years in 2020 and the types of EC products and flavors used by cigarette smokers who also used ECs at least monthly. Data came from 1253 adults aged ≥18 years who participated in the 2020 International Tobacco Control Malaysia Wave 1 Survey. Weighted descriptive statistics were used to estimate the prevalence of adults who reported ever using ECs and the prevalence who used ECs either monthly, weekly, or daily. The types of EC products and flavors used were compared by frequency of EC use among current smokers who used ECs at least monthly (n=459). Overall, 5.4% (95% CI: 3.7-7.5) of Malaysian adults reported using ECs on a daily basis in 2020. Among current cigarette smokers who used ECs daily, 81.0% (95% CI: 72.5-87.7) used nicotine in their ECs, 46.2% (95% CI: 37.8-54.7) used pre-filled ECs, and 60.4% (95% CI: 51.9-68.6) reported being somewhat/very addicted to ECs. The most common EC flavors were fruit, coffee, and menthol/ mint. Continued surveillance of EC use is necessary to monitor EC use in non-tobacco using populations while longitudinal research is needed to determine the extent to which ECs are, or are not, related to quitting smoking.
Identifiants
pubmed: 35431719
doi: 10.18332/tid/146363
pii: 32
pmc: PMC8969646
doi:
Types de publication
Journal Article
Langues
eng
Pagination
32Informations de copyright
© 2022 Driezen P. et al.
Déclaration de conflit d'intérêts
The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none was reported.
Références
BMJ. 2017 Jul 26;358:j3262
pubmed: 28747333
Addiction. 2019 Jun;114(6):1060-1073
pubmed: 30681215
Tob Control. 2008 Feb;17(1):46-52
pubmed: 18218808
Tob Control. 2006 Jun;15 Suppl 3:iii12-8
pubmed: 16754941
Tob Control. 2021 Feb 19;:
pubmed: 33608465
BMJ. 2019 Jun 20;365:l2219
pubmed: 31221636
Int J Environ Res Public Health. 2019 Aug 30;16(17):
pubmed: 31480240
N Engl J Med. 2019 Feb 14;380(7):629-637
pubmed: 30699054
Prev Med. 2018 Nov;116:13-18
pubmed: 30144487
MMWR Morb Mortal Wkly Rep. 2018 Nov 16;67(45):1276-1277
pubmed: 30439875
Tob Control. 2006 Jun;15 Suppl 3:iii3-11
pubmed: 16754944
JAMA. 2019 Nov 12;322(18):1824-1827
pubmed: 31524940
JAMA Intern Med. 2020 Oct 1;180(10):1394-1398
pubmed: 32897288
Am J Epidemiol. 2018 Nov 1;187(11):2397-2404
pubmed: 29955810
Tob Control. 2006 Jun;15 Suppl 3:iii71-5
pubmed: 16754950
BMJ. 2018 Jan 17;360:j5543
pubmed: 29343486
Addiction. 2008 Mar;103(3):502-8
pubmed: 18269370
Nicotine Tob Res. 2016 Apr;18(4):501-7
pubmed: 25895951
Int J Health Policy Manag. 2021 Apr 13;:
pubmed: 33906338
Tob Induc Dis. 2020 Mar 30;18:26
pubmed: 32292316
Lancet Respir Med. 2016 Nov;4(11):854-856
pubmed: 27743870
Asia Pac J Public Health. 2019 Oct;31(7_suppl):9S-21S
pubmed: 30880403
Nicotine Tob Res. 2008 May;10(5):907-15
pubmed: 18569766